Skip to main content

Transforming the understanding
and treatment of mental illnesses.

Celebrating 75 Years! Learn More >>

Introducing New HIV Prevention Products: The Dapivirine Ring and Injectable Cabotegravir for PrEP

Date and Time

July 20, 2022
10:00–11:00 a.m. ET




In 2021, the U.S. Agency for International Development (USAID) launched Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC) , a new $85 million program funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to help women around the world protect themselves from HIV. The National Institute of Mental Health (NIMH) is conducting a webinar about new HIV Pre-Exposure Prophylaxis (PrEP) product introduction planning in Africa, including an overview of the CATALYST implementation study exploring PrEP choice.

Presenters and panelists include:

  • Kristine Torjesen, M.D., MPH, Director of the Science Facilitation Department at FHI 360 and the Project Director for the MOSAIC project
  • Elizabeth Irungu, MBChB, MPH, Ph.D., a Regional Technical Advisor at Jhpiego
  • Patriciah Jeckonia, Senior Technical Advisor for policy and partnerships and Project Manager for MOSAIC
  • Imelda Mahaka, Executive Director for Pangaea Zimbabwe AIDS Trust (PZAT)
  • Nicolette Naidoo, MPH, Programme Head of Implementation Science at the Wits Reproductive Health and HIV Institute

Sponsored by

Division of AIDS Research



This event is free but you must register to attend.